Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 99, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2021.108046
Keywords
NLRP3; MCC950; Pressure overload; Heart failure; Inflammation; Cardiac remodeling
Categories
Funding
- National Natural Science Foundation of China [82070436]
- Natural Science Foundation of Hubei Province [2020CFB234]
Ask authors/readers for more resources
The study revealed that the NLRP3 inhibitor MCC950 could reverse cardiac remodeling induced by transverse aortic constriction (TAC), improving cardiac dysfunction, reducing cardiac hypertrophy and fibrosis, and decreasing inflammation and macrophage infiltration.
Activation of the NLRP3 inflammasome promotes pathological cardiac remodeling induced by pressure overload. However, the therapeutic effects of NLRP3 inhibition after cardiac remodeling remain unknown. The present study aimed to investigate whether the selective NLRP3 inhibitor, MCC950, could reverse transverse aortic constriction (TAC)-induced cardiac remodeling. Mice were divided into four groups based on the treatment given: sham, sham + MCC950, TAC, and TAC + MCC950. MCC950 (10 mg/kg, intraperitoneal injection, once per day) was administered from two weeks after TAC or sham surgery for four weeks. Echocardiography, histological analysis, RT-PCR, and Western blotting were performed to explore the function of MCC950 after TAC. We found that MCC950 reversed cardiac dysfunction after TAC. MCC950 attenuated cardiac hypertrophy by down-regulating calcineurin expression and inhibiting MAPK activation. Further, it also alleviated cardiac fibrosis post-TAC by inhibiting the TGF-beta/Smad4 pathway, and reduced cardiac inflammation and macrophage infiltration post-TAC, including both Ml and M2 macrophages. Taken together, MCC950 can attenuate cardiac remodeling due to pressure overload by inhibiting hypertrophy, fibrosis, and inflammation. Our study provides a basis for the clinical application of NLRP3 inhibitors in the treatment of non-ischemic heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available